MASP2 and infarction: In mice, genetic MASP-2 deficiency or pretreatment with MASP-2–inhibitory mAbs was shown to result in smaller infarction size in myocardial and gastrointestinal IR injury models (16, 42) and to reduce neurological deficit and histopathological lesion after focal cerebral ischemia (18).